UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is the Disease-Specific Lupusqol Sensitive To Changes of Disease Activity In Systemic Lupus Erythematosus Patients After Treatment of A Flare?

Value in health, 2014-11, Vol.17 (7), p.A538-A538

2014

Volltextzugriff (PDF)

PRM92 Exploratory Mapping of the LupusQol to the SF-6D

Value in health, 2012-11, Vol.15 (7), p.A477-A477

2012

Volltextzugriff (PDF)

OP0043 Corticosteroid Use over Time in The Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort - A Descriptive Analysis: Table 1

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.70-70

2016

Volltextzugriff (PDF)

THU0294 An International Consensus Exercise To Classify SLE Damage Items According To Their Likely Association with Steroids: Table 1

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.293-293

2016

Volltextzugriff (PDF)

Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients

The pharmacogenomics journal, 2013-06, Vol.13 (3), p.227-234

2013

Volltextzugriff (PDF)

Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey

British journal of dermatology (1951), 2021-07, Vol.185 (1), p.80-90

2021

Volltextzugriff (PDF)

MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms

The pharmacogenomics journal, 2013-04, Vol.13 (2), p.137-147

2013

Volltextzugriff (PDF)

FRI0426 High Prevalence of Overweight and Obesity in Recently Diagnosed Systemic Lupus Erythematosus Patients in an International Registry: Table 1

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.541-541

2014

Volltextzugriff (PDF)

OP0043 Corticosteroid Use over Time in The Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort - A Descriptive Analysis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.70

2016

Volltextzugriff (PDF)

THU0294 An International Consensus Exercise To Classify SLE Damage Items According To Their Likely Association with Steroids

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.293

2016

Volltextzugriff (PDF)

SAT0281 Compensatory Brain Mechanisms To Maintain Cognitive Function in Systemic Lupus Erythematosus

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.769-770

2016

Volltextzugriff (PDF)

Efficacité et tolérance du traitement séquentiel belimumab (BEL) sous-cutané et rituximab (RTX) chez des patients atteints de lupus systémique (LS) : étude BLISS-BELIEVE de phase 3, randomisée, contrôlée versus placebo

La revue de medecine interne, 2022-06, Vol.43, p.A80-A80

2022

Volltextzugriff (PDF)

FRI0426 High Prevalence of Overweight and Obesity in Recently Diagnosed Systemic Lupus Erythematosus Patients in an International Registry

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.541

2014

Volltextzugriff (PDF)

THU0163 Predictors of metabolic syndrome at enrolment into a multicentre international inception cohort of patients with SLE

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.210-211

2013

Volltextzugriff (PDF)

SAT0214 Elevated endothelial microparticle levels correlate with endothelial function in active SLE

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.544-544

2013

Volltextzugriff (PDF)

AB0969 Reliability of Measuring Aortic Stiffness in A Routine Rheumatology Clinic Setting

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.1120-1120

2014

Volltextzugriff (PDF)

Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue disease

BBA clinical, 2017-06, Vol.7, p.16-22

2017

Volltextzugriff (PDF)

SAT0225 Urinary monocyte chemoattractant protein-1 (UMCP1) in SLE, a biomarker of renal or more general disease?

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.548-548

2013

Volltextzugriff (PDF)

OP0186 5-Year Organ Damage Accrual and Safety in Patients with Sle Treated with Belimumab Plus Standard of Care

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.142-142

2015

Volltextzugriff (PDF)

OP0047 Metabolic and Lifestyle Predictors of Inflammatory Polyarthritis in the EPIC-2-NOAR Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.84-84

2015

Volltextzugriff (PDF)

OP0268 Anti-Citrullinated Protein Antibody (ACPA) Status in the General Population and as a Predictor of Future Inflammatory Polyarthritis: The EPIC-2-Noar Study

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.173-173

2015

Volltextzugriff (PDF)

Lack of awareness of skin cancer among immunocompromised patients with antineutrophil cytoplasmic antibody-associated vasculitis: a questionnaire survey

British journal of dermatology (1951), 2014-07, Vol.171 (1), p.193-195

2014

Volltextzugriff (PDF)

PSY95 - Is the Disease-Specific Lupusqol Sensitive To Changes of Disease Activity In Systemic Lupus Erythematosus Patients After Treatment of A Flare?

Value in health, 2014-11, Vol.17 (7), p.A538-A538

2014

Volltextzugriff (PDF)

SAT0007 Fine-mapping of the 5Q31 psoriatic arthritis susceptibility LOCI in a british population

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.473-473

2013

Volltextzugriff (PDF)

THU0003 Fine-mapping of autoimmune susceptibility LOCI using immunochip identifies novel susceptibility LOCI for psoriatic arthritis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.154-155

2013

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Is the Disease-Specific Lupusqol Sensitive To Changes of Disease Activity In Systemic Lupus Erythematosus Patients After Treatment of A Flare?

PRM92 Exploratory Mapping of the LupusQol to the SF-6D

OP0043 Corticosteroid Use over Time in The Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort - A Descriptive Analysis: Table 1

THU0294 An International Consensus Exercise To Classify SLE Damage Items According To Their Likely Association with Steroids: Table 1

Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients

Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey

MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms

FRI0426 High Prevalence of Overweight and Obesity in Recently Diagnosed Systemic Lupus Erythematosus Patients in an International Registry: Table 1

OP0043 Corticosteroid Use over Time in The Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort - A Descriptive Analysis

THU0294 An International Consensus Exercise To Classify SLE Damage Items According To Their Likely Association with Steroids

SAT0281 Compensatory Brain Mechanisms To Maintain Cognitive Function in Systemic Lupus Erythematosus

Efficacité et tolérance du traitement séquentiel belimumab (BEL) sous-cutané et rituximab (RTX) chez des patients atteints de lupus systémique (LS) : étude BLISS-BELIEVE de phase 3, randomisée, contrôlée versus placebo

FRI0426 High Prevalence of Overweight and Obesity in Recently Diagnosed Systemic Lupus Erythematosus Patients in an International Registry

THU0163 Predictors of metabolic syndrome at enrolment into a multicentre international inception cohort of patients with SLE

SAT0214 Elevated endothelial microparticle levels correlate with endothelial function in active SLE

AB0969 Reliability of Measuring Aortic Stiffness in A Routine Rheumatology Clinic Setting

Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue disease

SAT0225 Urinary monocyte chemoattractant protein-1 (UMCP1) in SLE, a biomarker of renal or more general disease?

OP0186 5-Year Organ Damage Accrual and Safety in Patients with Sle Treated with Belimumab Plus Standard of Care

OP0047 Metabolic and Lifestyle Predictors of Inflammatory Polyarthritis in the EPIC-2-NOAR Study

OP0268 Anti-Citrullinated Protein Antibody (ACPA) Status in the General Population and as a Predictor of Future Inflammatory Polyarthritis: The EPIC-2-Noar Study

Lack of awareness of skin cancer among immunocompromised patients with antineutrophil cytoplasmic antibody-associated vasculitis: a questionnaire survey

PSY95 - Is the Disease-Specific Lupusqol Sensitive To Changes of Disease Activity In Systemic Lupus Erythematosus Patients After Treatment of A Flare?

SAT0007 Fine-mapping of the 5Q31 psoriatic arthritis susceptibility LOCI in a british population

THU0003 Fine-mapping of autoimmune susceptibility LOCI using immunochip identifies novel susceptibility LOCI for psoriatic arthritis

Suchergebnisse filtern